ES2196620T3 - Formulacion de liberacion prolongada que contiene venlafaxina. - Google Patents

Formulacion de liberacion prolongada que contiene venlafaxina.

Info

Publication number: ES2196620T3
Authority: ES; Spain
Prior art keywords: formulation; prolonged release; release containing; containing venlafaxine; venlafaxine
Prior art date: 1997-11-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

ES98956487T

Other languages

English (en)

Spanish (es)

Inventor

Deborah Marie Sherman

John Clifton Clark

John Ulrick Lamer

Stephen Andrew White

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Wyeth LLC

Original Assignee

Wyeth LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-05

Filing date

1998-11-03

Publication date

2003-12-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25508423&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2196620(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-11-03 Application filed by Wyeth LLC filed Critical Wyeth LLC

2003-12-16 Application granted granted Critical

2003-12-16 Publication of ES2196620T3 publication Critical patent/ES2196620T3/es

2018-11-03 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
230000002035 prolonged effect Effects 0.000 title 1
PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical compound C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 title 1
229960004688 venlafaxine Drugs 0.000 title 1
229920000168 Microcrystalline cellulose Polymers 0.000 abstract 1
239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 1
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 1
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
235000019813 microcrystalline cellulose Nutrition 0.000 abstract 1
239000008108 microcrystalline cellulose Substances 0.000 abstract 1
229940016286 microcrystalline cellulose Drugs 0.000 abstract 1
229960002416 venlafaxine hydrochloride Drugs 0.000 abstract 1
QYRYFNHXARDNFZ-UHFFFAOYSA-N venlafaxine hydrochloride Chemical compound [H+].[Cl-].C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 QYRYFNHXARDNFZ-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ES98956487T 1997-11-05 1998-11-03 Formulacion de liberacion prolongada que contiene venlafaxina. Expired - Lifetime ES2196620T3 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US96432897A	1997-11-05	1997-11-05

Publications (1)

Publication Number	Publication Date
ES2196620T3 true ES2196620T3 (es)	2003-12-16

Family

ID=25508423

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES98956487T Expired - Lifetime ES2196620T3 (es)	1997-11-05	1998-11-03	Formulacion de liberacion prolongada que contiene venlafaxina.

Country Status (38)

Country	Link
EP (1)	EP1028718B1 (et)
JP (1)	JP2001521892A (et)
KR (1)	KR20010031797A (et)
CN (1)	CN1278165A (et)
AR (1)	AR014012A1 (et)
AT (1)	ATE237320T1 (et)
AU (1)	AU747978B2 (et)
BG (1)	BG104397A (et)
BR (1)	BR9813179A (et)
CA (1)	CA2305242A1 (et)
CL (1)	CL2004001705A1 (et)
CO (1)	CO5011060A1 (et)
CZ (1)	CZ20001659A3 (et)
DE (1)	DE69813602T2 (et)
DK (1)	DK1028718T3 (et)
EA (1)	EA200000487A1 (et)
EE (1)	EE04577B1 (et)
ES (1)	ES2196620T3 (et)
GE (1)	GEP20043198B (et)
HR (1)	HRP20000213B1 (et)
HU (1)	HU225238B1 (et)
ID (1)	ID26317A (et)
IL (1)	IL135457A0 (et)
MA (1)	MA24691A1 (et)
NO (1)	NO20002126L (et)
NZ (1)	NZ504460A (et)
PA (1)	PA8462501A1 (et)
PE (1)	PE128699A1 (et)
PL (1)	PL341141A1 (et)
PT (1)	PT1028718E (et)
SK (1)	SK6472000A3 (et)
SV (1)	SV1998000131A (et)
TR (1)	TR200001232T2 (et)
TW (1)	TW555568B (et)
UA (1)	UA77145C2 (et)
UY (2)	UY25234A1 (et)
WO (1)	WO1999022724A2 (et)
ZA (1)	ZA9810081B (et)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE60039132D1 (de) *	1999-04-06	2008-07-17	Sepracor Inc	O-Desmethylvenlafaxin-Succinat
ATE367153T1 (de) *	1999-05-20	2007-08-15	Elan Corp Plc	Multipartikuläre arzneizusammensetzungen mit gesteuerter wirkstoffabgabe enthaltend selektive inhibitoren der serotoninwiederaufnahme
IL146462A (en) *	2001-11-13	2015-02-26	Lycored Bio Ltd	Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
CN1630631A (zh) *	2001-12-05	2005-06-22	惠氏公司	新的文拉法星盐酸盐多晶型物及其制备方法
WO2003050074A1 (en) *	2001-12-13	2003-06-19	Cadila Healthcare Limited	Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
WO2003055475A1 (en) *	2002-01-03	2003-07-10	Lek Pharmaceutical And Chemical Company D.D.	Controlled release pharmaceutical formulation containing venlafaxine
US20030190352A1 (en) *	2002-03-28	2003-10-09	Synthon Bv	Compositions of venlafaxine base
AU2003219117A1 (en) *	2002-03-28	2003-10-13	Synthon B.V.	Extended release venlafaxine formulations
US6696496B2 (en)	2002-03-28	2004-02-24	Synthon Bv	Low water-soluble venlafaxine salts
EP1485344A1 (en)	2002-03-28	2004-12-15	Synthon B.V.	Venlafaxine besylate
FR2845289B1 (fr)	2002-10-04	2004-12-03	Ethypharm Sa	Spheroides, procede de preparation et compositions pharmaceutiques.
CA2415154C (en) *	2002-12-24	2009-06-16	Biovail Laboratories Inc.	Modified release formulations of selective serotonin re-uptake inhibitors
DE10350194B4 (de) *	2003-10-28	2005-11-10	Bioplanta Arzneimittel Gmbh	Verwendung von Extrakten aus Opuntien zur Behandlung von depressiven Verstimmungen und Erkrankungen
TW200503670A (en) *	2003-03-28	2005-02-01	Sandoz Ag	Venlafaxine compositions
ATE336988T1 (de) *	2003-07-30	2006-09-15	Pharmathen Sa	Venlafaxine hydrochloridformulierungen mit verzögerter freisetzung
HUP0303382A2 (hu) *	2003-10-10	2005-08-29	EGIS Gyógyszergyár Rt.	Venlafaxin-hidroklorid-tartalmú pelletek
AU2004315136B2 (en)	2004-02-04	2010-06-17	Alembic Limited	Extended release coated microtablets of venlafaxine hydrochloride
US7776358B2 (en)	2004-07-22	2010-08-17	Synthon Ip Inc.	Extended release venlafaxine besylate tablets
US20190083399A9 (en) *	2006-04-03	2019-03-21	Isa Odidi	Drug delivery composition
WO2007129329A2 (en) *	2006-05-08	2007-11-15	Jubilant Organosys Limited	Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
CN102772390B (zh) *	2012-08-16	2014-01-08	乐普药业股份有限公司	一种盐酸文拉法辛缓释胶囊及其制备方法
FR3080278B1 (fr) *	2018-04-11	2021-04-30	Ghs Patents Ltd	Procede de fabrication d'un spheroide de cannabidiol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1561204A (en) *	1977-06-01	1980-02-13	Ici Ltd	Sustained release pharmaceutical composition
US6440457B1 (en) *	1993-05-27	2002-08-27	Alza Corporation	Method of administering antidepressant dosage form
PE57198A1 (es) *	1996-03-25	1998-10-10	American Home Prod	Formula de liberacion prolongada
ZA97976B (en) *	1996-04-05	1997-08-18	Alza Corp	Uniform drug delivery theraphy.

1998
- 1998-03-11 UA UA2000063197A patent/UA77145C2/uk unknown
- 1998-10-30 PA PA19988462501A patent/PA8462501A1/es unknown
- 1998-11-02 MA MA25330A patent/MA24691A1/fr unknown
- 1998-11-03 TR TR2000/01232T patent/TR200001232T2/xx unknown
- 1998-11-03 WO PCT/US1998/023338 patent/WO1999022724A2/en not_active Ceased
- 1998-11-03 PT PT98956487T patent/PT1028718E/pt unknown
- 1998-11-03 EP EP98956487A patent/EP1028718B1/en not_active Revoked
- 1998-11-03 SK SK647-2000A patent/SK6472000A3/sk unknown
- 1998-11-03 IL IL13545798A patent/IL135457A0/xx unknown
- 1998-11-03 EE EEP200000212A patent/EE04577B1/et not_active IP Right Cessation
- 1998-11-03 ID IDW20000834A patent/ID26317A/id unknown
- 1998-11-03 JP JP2000518658A patent/JP2001521892A/ja active Pending
- 1998-11-03 EA EA200000487A patent/EA200000487A1/ru unknown
- 1998-11-03 DE DE69813602T patent/DE69813602T2/de not_active Revoked
- 1998-11-03 AT AT98956487T patent/ATE237320T1/de not_active IP Right Cessation
- 1998-11-03 CZ CZ20001659A patent/CZ20001659A3/cs unknown
- 1998-11-03 PL PL98341141A patent/PL341141A1/xx not_active Application Discontinuation
- 1998-11-03 GE GEAP19985388A patent/GEP20043198B/en unknown
- 1998-11-03 NZ NZ504460A patent/NZ504460A/xx unknown
- 1998-11-03 CO CO98064480A patent/CO5011060A1/es unknown
- 1998-11-03 BR BR9813179-6A patent/BR9813179A/pt not_active Application Discontinuation
- 1998-11-03 DK DK98956487T patent/DK1028718T3/da active
- 1998-11-03 AU AU13003/99A patent/AU747978B2/en not_active Ceased
- 1998-11-03 HU HU0004287A patent/HU225238B1/hu not_active IP Right Cessation
- 1998-11-03 CA CA002305242A patent/CA2305242A1/en not_active Abandoned
- 1998-11-03 ES ES98956487T patent/ES2196620T3/es not_active Expired - Lifetime
- 1998-11-03 KR KR1020007004865A patent/KR20010031797A/ko not_active Ceased
- 1998-11-03 TW TW086102797A patent/TW555568B/zh not_active IP Right Cessation
- 1998-11-03 HR HR20000213A patent/HRP20000213B1/xx not_active IP Right Cessation
- 1998-11-03 CN CN98810881A patent/CN1278165A/zh active Pending
- 1998-11-04 ZA ZA9810081A patent/ZA9810081B/xx unknown
- 1998-11-04 AR ARP980105563A patent/AR014012A1/es unknown
- 1998-11-04 SV SV1998000131A patent/SV1998000131A/es not_active Application Discontinuation
- 1998-11-04 PE PE1998001045A patent/PE128699A1/es not_active Application Discontinuation
- 1998-11-05 UY UY25234A patent/UY25234A1/es not_active IP Right Cessation
1999
- 1999-09-03 UY UY25692A patent/UY25692A1/es not_active IP Right Cessation
2000
- 2000-04-26 NO NO20002126A patent/NO20002126L/no not_active Application Discontinuation
- 2000-05-04 BG BG104397A patent/BG104397A/xx unknown
2004
- 2004-07-06 CL CL200401705A patent/CL2004001705A1/es unknown

Also Published As

Publication number	Publication date
HK1029056A1 (en)	2001-03-23
ID26317A (id)	2000-12-14
EA200000487A1 (ru)	2000-10-30
EE04577B1 (et)	2006-02-15
BR9813179A (pt)	2000-08-22
WO1999022724A2 (en)	1999-05-14
KR20010031797A (ko)	2001-04-16
NO20002126D0 (no)	2000-04-26
CO5011060A1 (es)	2001-02-28
UA77145C2 (en)	2006-11-15
DE69813602T2 (de)	2003-11-06
DK1028718T3 (da)	2003-07-28
EP1028718A2 (en)	2000-08-23
PE128699A1 (es)	2000-01-06
ZA9810081B (en)	2000-05-04
AR014012A1 (es)	2001-01-31
CL2004001705A1 (es)	2005-06-03
ATE237320T1 (de)	2003-05-15
GEP20043198B (en)	2004-03-25
NZ504460A (en)	2003-01-31
TR200001232T2 (tr)	2000-12-21
SV1998000131A (es)	1999-11-18
CN1278165A (zh)	2000-12-27
PL341141A1 (en)	2001-03-26
CA2305242A1 (en)	1999-05-14
HUP0004287A2 (hu)	2002-04-29
WO1999022724A3 (en)	1999-07-22
MA24691A1 (fr)	1999-07-01
BG104397A (en)	2001-02-28
AU1300399A (en)	1999-05-24
NO20002126L (no)	2000-05-04
HU225238B1 (en)	2006-08-28
EP1028718B1 (en)	2003-04-16
EE200000212A (et)	2001-04-16
JP2001521892A (ja)	2001-11-13
HRP20000213B1 (en)	2004-04-30
IL135457A0 (en)	2001-05-20
DE69813602D1 (de)	2003-05-22
UY25692A1 (es)	2000-03-31
UY25234A1 (es)	2000-12-29
TW555568B (en)	2003-10-01
SK6472000A3 (en)	2000-11-07
HRP20000213A2 (en)	2000-12-31
CZ20001659A3 (cs)	2001-10-17
PT1028718E (pt)	2003-07-31
AU747978B2 (en)	2002-05-30
PA8462501A1 (es)	2000-05-24
HUP0004287A3 (en)	2002-05-28

Publication	Publication Date	Title
ES2196620T3 (es)	2003-12-16	Formulacion de liberacion prolongada que contiene venlafaxina.
MEP3608A (en)	2011-05-10	Modified-release tablet of bupropion hydrochloride
CO4750807A1 (es)	1999-03-31	Solucion de interferon
ATE268593T1 (de)	2004-06-15	Bupropionhydrochlorid enthaltende tabletten mit gesteuerter wirkstoffabgabe
TR199800077T1 (xx)	1998-05-21	Kontroll� ��z�len paroksetin terkipleri.
BR0011489A (pt)	2002-03-05	Composições formadoras de pelìcula compreendendo amidos modificados e iota-carragenano e processos para a fabricação de cápsulas macias usando as mesmas
BRPI0013439B1 (pt)	2012-07-24	composiÇço compreendendo tramadol e um fÁrmaco anticonvulsivante.
BR0006861A (pt)	2001-07-10	Processo de possibilitar que uma primeira rede doméstica de uma primeira arquitetura de software interaja com uma segunda rede doméstica de uma segunda arquitetura de software, sistema de processamento de informações, e, componente de software para uso em um sistema de ambiente doméstico
WO2004108067A3 (en)	2005-07-28	Programmed drug delivery system
BR0207775A (pt)	2004-03-30	Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
DE59911249D1 (de)	2005-01-13	Substituierte 2-phenylbenzimidazole, deren herstellung und anwendung
BR0109943A (pt)	2003-05-27	Composições farmacêuticas
AR025247A1 (es)	2002-11-13	Composiciones de granulos de carotenos-xantofilos, estables
DE50202328D1 (de)	2005-03-31	Amidofunktionelle aminopolydiorganosiloxane
DK0736525T3 (da)	2000-10-30	Benzonitriler som 5-HT-agonister og -antagonister
ES2046852T3 (es)	1994-02-01	Un procedimiento para preparar un champu.
BRPI0412697A (pt)	2006-10-03	composições farmacêuticas que apresentam um revestimento expansìvel
DK0984960T3 (da)	2003-05-26	N-triazol-2-indolcarboxamider og deres anvendelse som CCK-A-agonister
ES2191417T3 (es)	2003-09-01	Composicion desinfectante.
BRPI0012553B8 (pt)	2021-05-25	pastilha contendo cloridrato de ambroxol, seu processo de preparação e seu uso
MA26666A1 (fr)	2004-12-20	Antioxide, composition antiproliferee, y compris carnitine et carotenoide.
TR200000697T2 (tr)	2001-01-22	İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
YU49313B (sh)	2005-06-10	Lipozomni preparat koji sadrži selegilin i/ili njegovu so
EP0616800A3 (en)	1995-02-15	Rieck fabric agent with extended diffusion.
MX9909797A (es)	2000-07-31	Composiciones para el cuidado personal que comprenden un copolimero adhesivo.